Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide in Leptomeningeal Metastases
NCT00005812Phase 2Terminated
- Sponsor
- Dartmouth Health
- Start
- Jan 2000
- Primary completion
- May 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in leptomeningeal metastases (LM), sponsored by Dartmouth Health. Started Jan 2000; status: terminated.
02
Drugs
temozolomide
03
Conditions
leptomeningeal metastases (LM)
Beyond the preview
Go deeper on NCT00005812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005812.